Refoxy Pharmaceuticals (Seed extension)
Funding Details
- Awarder
- Inbox
- Date Award
- December 04, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $9,100,000
Company Info
- Founders
- Dr. Victor Bustos, Prof. Wolfgang Link
- Company Description
- Refoxy Pharmaceuticals is a preclinical biotech company developing small molecule activators of the FOXO3 transcription factor for the treatment of age-related diseases. The company is focused on advancing the development of new therapeutic medicines, starting with idiopathic pulmonary fibrosis (IPF).
- Market
- Pharmaceuticals
- Location
- Berlin, Germany
- Coinvestors
- Boehringer Ingelheim Venture Fund, Apollo Heath Ventures, NRW.Venture, High-Tech Gründerfonds